{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:26:36Z","timestamp":1785767196896,"version":"3.56.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016808","name":"Natural Science Foundation of Xiamen Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the incidence, diagnostic performance, clinical characteristics, and prognostic determinants of invasive pulmonary aspergillosis (IPA) in critically ill patients, using updated EORTC\/MSG and FUNDICU criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed a heterogenous ICU pneumonia cohort between Jan 2022 and Jun 2025. All included patients underwent at least one mycological assessment. IPA was diagnosed based on integrated EORTC\/MSG and FUNDICU criteria. Diagnostic accuracy of mycological assays was evaluated, and clinical profiles were compared between IPA and non-IPA patients. Independent risk factors for mortality were identified via multivariate Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1835 patients, the IPA incidence was 7.1% (n=131). Of all mycological assays, bronchoalveolar lavage fluid galactomannan (BALF GM) demonstrated the highest sensitivity (85.5%) with robust specificity (82.9%). Molecular testing combined with BALF GM yielded a sensitivity of 64.4% and a specificity of 80.0%. Serum GM exhibited the lowest sensitivity (41.7%) but the highest specificity (89.2%); its combination with culture or molecular methods further enhanced specificity to &amp;gt;95%. Although patchy infiltrates were the most frequent radiological findings in both groups, consolidation (63.4% vs. 40.3%,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), nodules (22.9% vs. 9.1%,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.014), cavities (17.6% vs 3.9%,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.004), and tree-in-bud signs (9.9% vs. 1.3%\n                      <jats:italic>, P<\/jats:italic>\n                      = 0.019) were significantly more prevalent in IPA patients. IPA patients experienced longer ICU stays (median 20 vs. 16 days) and significantly higher ICU mortality (55.0% vs 26.0%). Multivariable analysis identified IPA (HR: 2.064, 95% CI = 1.211-3.518,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.008) and a prolonged interval from admission to the first positive mycological test (HR: 1.017, 95% CI = 1.004-1.031,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.011) as independent risk factors for death. Conversely, anti-\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      therapy (HR: 0.489, 95% CI = 0.275-0.871,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.015) and tracheostomy (HR: 0.351, 95% CI = 0.222-0.557,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001) were associated with improved survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IPA is a common and lethal complication in ICU pneumonia patients, serving as an independent predictor of mortality. BALF GM, particularly when integrated with molecular testing, is the most effective mycological diagnostic method. Reducing the diagnostic window, initiating timely antifungal therapy, and proactive airway management (e.g., tracheostomy) may significantly improve clinical outcome for these critically ill patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1732182","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:31:17Z","timestamp":1771828277000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosis, clinical features and survival analysis of invasive pulmonary aspergillosis among critically ill patients: a retrospective cohort study based on updated criteria"],"prefix":"10.3389","volume":"16","author":[{"given":"Liufang","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Intensive Care Unit, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University","place":["Xiamen, China"]},{"name":"The Graduate School of Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiwen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University","place":["Xiamen, China"]},{"name":"The Graduate School of Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University","place":["Xiamen, China"]},{"name":"The Graduate School of Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhe","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University","place":["Xiamen, China"]},{"name":"The Graduate School of Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University","place":["Xiamen, China"]},{"name":"The Graduate School of Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaogui","family":"Ning","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University","place":["Xiamen, China"]},{"name":"The Graduate School of Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","article-title":"Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions of fungal disease from the EORTC\/MSGERC","volume":"72","author":"Alexander","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3390\/diagnostics12071617","article-title":"Co-infections and superinfections in COVID-19 critically ill patients are associated with CT imaging abnormalities and the worst outcomes","volume":"12","author":"Brandi","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jamaoto.2021.0025","article-title":"Association of early vs late tracheostomy placement with pneumonia and ventilator days in critically ill patients: A meta-analysis","volume":"147","author":"Chorath","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00134-025-07797-1","article-title":"Invasive fungal infections in patients with liver disease: immunological and clinical considerations for the intensive care unit","volume":"51","author":"Epelbaum","year":"2025","journal-title":"Intensive Care Med."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1587227","article-title":"Evaluation of the clinical characteristics and survival outcomes of invasive pulmonary aspergillosis patients","volume":"16","author":"Feng","year":"2025","journal-title":"Front. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","article-title":"Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients","volume":"12","author":"Feys","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/diagnostics12051201","article-title":"Clinical and imaging features of COVID-19-associated pulmonary aspergillosis","volume":"12","author":"Fischer","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/apm.13316","article-title":"Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices","volume":"131","author":"Gaffney","year":"2023","journal-title":"APMIS"},{"key":"B13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jointm.2024.01.005","article-title":"Fungal infections in immunocompromised critically ill patients","volume":"4","author":"Garnacho-Montero","year":"2024","journal-title":"J. Intensive Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/crj.13585","article-title":"Aspergillus infection in chronic obstructive pulmonary diseases","volume":"17","author":"Guo","year":"2023","journal-title":"Clin. Respir. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jcrc.2017.11.037","article-title":"Early vs. late tracheostomy in intensive care settings: Impact on ICU and hospital costs","volume":"44","author":"Herritt","year":"2018","journal-title":"J. Crit. Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-0043-1777769","article-title":"Acute invasive pulmonary aspergillosis: clinical presentation and treatment","volume":"45","author":"Heylen","year":"2024","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jmoldx.2024.06.003","article-title":"The utility of real-time PCR, metagenomic next-generation sequencing, and culture in bronchoalveolar lavage fluid for diagnosis of pulmonary aspergillosis","volume":"26","author":"Hu","year":"2024","journal-title":"J. Mol. Diagn."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s10096-021-04228-z","article-title":"Diagnostic value of galactomannan test in non-immunocompromised critically ill patients with influenza-associated aspergillosis: data from three consecutive influenza seasons","volume":"40","author":"Huang","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/jof9020131","article-title":"Invasive pulmonary aspergillosis","volume":"9","author":"Ledoux","year":"2023","journal-title":"J. Fungi (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007394.pub2","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"2015","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s40121-023-00818-w","article-title":"A comparison of diagnostic criteria for invasive pulmonary aspergillosis in critically ill patients","volume":"12","author":"Liu","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12931-020-01424-x","article-title":"Airway-invasion-associated pulmonary computed tomography presentations characteristic of invasive pulmonary Aspergillosis in non-immunocompromised adults: a National Multicenter Retrospective Survey in China","volume":"21","author":"Liu","year":"2020","journal-title":"Respir. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1164\/rccm.202002-0355OC","article-title":"Pulmonary aspergillosis in patients with suspected ventilator-associated pneumonia in UK ICUs","volume":"202","author":"Loughlin","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.chest.2023.09.019","article-title":"Prevalence, risk factors, clinical features, and outcome of influenza-associated pulmonary aspergillosis in critically ill patients: A systematic review and meta-analysis","volume":"165","author":"Lu","year":"2024","journal-title":"Chest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/life14091165","article-title":"Timing of tracheostomy in ICU patients: A systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Merola","year":"2024","journal-title":"Life (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.3390\/diagnostics13162718","article-title":"Microbiological non-culture-based methods for diagnosing invasive pulmonary aspergillosis in ICU patients","volume":"13","author":"Scharmann","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/myc.13478","article-title":"Comparison of four diagnostic criteria for invasive pulmonary aspergillosis-A diagnostic accuracy study in critically ill patients","volume":"65","author":"Schroeder","year":"2022","journal-title":"Mycoses"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/jac\/dkab317","article-title":"When to change treatment of acute invasive aspergillosis: an expert viewpoint","volume":"77","author":"Slavin","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1164\/rccm.202208-1570OC","article-title":"A pathology-based case series of influenza- and COVID-19-associated pulmonary aspergillosis: the proof is in the tissue","volume":"208","author":"Vanderbeke","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1522217","article-title":"Clinical characteristics and prognosis of COVID-19- associated invasive pulmonary aspergillosis in critically patients: a single-center study","volume":"15","author":"Xiao","year":"2025","journal-title":"Front. Cell Infect. Microbiol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1732182\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:31:18Z","timestamp":1771828278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1732182\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":31,"alternative-id":["10.3389\/fcimb.2026.1732182"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1732182","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"article-number":"1732182"}}